Genelux Corporation
Clinical trials sponsored by Genelux Corporation, explained in plain language.
-
Virus therapy shows promise for tough lung cancers
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after standard first-line treatment. Participants receive an experimental virus (Olvi-Vec) followed by chemotherapy plus an immunotherapy drug, or the standard chemotherapy docetaxel alon…
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Virus therapy shows promise for Drug-Resistant ovarian cancer in major new trial
Disease control Recruiting nowThis study tests a new treatment called Olvi-Vec, a virus that targets cancer cells, followed by standard chemotherapy and bevacizumab, in women with ovarian cancer that no longer responds to platinum-based drugs. About 186 participants will be randomly assigned to receive either…
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC